Molecules Engineered Against Oncogenic Proteins and CancerA comprehensive review of the latest molecular advances in cancer treatment Featuring 91 total small molecule kinase KRAS inhibitors, 80 of which are FDA approved, Molecules Engineered Against Oncogenic Proteins and Cancer documents the recent scientific advances that have transformed one of medicines most challenging areascancer treatment. Most of these inhibitors specifically block oncogene induced carcinogenic proteins with results that have